Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $199.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 12.47% year-over-year to $199.2 million, compared with a TTM value of $764.2 million through Dec 2025, up 14.84%, and an annual FY2025 reading of $199.2 million, up 12.47% over the prior year.
  • Liabilities and Shareholders Equity was $199.2 million for Q4 2025 at Viemed Healthcare, down from $202.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $202.4 million in Q3 2025 and bottomed at $111.0 million in Q2 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $146.8 million, with a median of $149.3 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity decreased 1.04% in 2021, then surged 32.34% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $118.0 million in 2021, then fell by 0.78% to $117.0 million in 2022, then skyrocketed by 32.34% to $154.9 million in 2023, then increased by 14.32% to $177.1 million in 2024, then grew by 12.47% to $199.2 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for VMD at $199.2 million in Q4 2025, $202.4 million in Q3 2025, and $184.6 million in Q2 2025.